Some Basic Facts about 20543: The Power of Consumer Reporting


What is the 20543 short code used to report?

In its bid to ensure safety of Nigerians as it relates to medicines and to get consumer feedback on adverse drug reactions, the National Agency for Food and Drug Administration and Control (NAFDAC) established a toll free platform for reporting adverse drug reactions in Nigeria. Consumers can simply text a description of the symptoms they have experienced after taking medicines in Nigeria to 20543.

What information should I text if I have suffered an adverse drug reaction?

If you suspect that you have had an adverse drug reaction, you should text a description of your symptoms to 20543. When the information gets to NAFDAC, their Pharmocovigilance Center will give you a call in order to get additional information that will enable the agency determine whether or not an adverse reaction has taken place. It is important to note that NAFDAC does not provide clinical/hospital treatment following such reports but the information is very helpful to the public including the consumer, as NAFDAC uses that information (in addition to other data) to advice the public on who should not take the medication. For example, if it affects the elderly, people who are hypertensive, have asthma or is just not suitable for the entire Nigerian population as a whole.

What phone networks accept the SMS short code 20453?

MTN, Etisalaat and Glo subscribers can all send free text messages to 20543 to report cases of adverse drug reactions. Such reports are very helpful in assisting the agency in its work in safeguarding the health of all Nigerians.

What is PRASCOR?

PRASCOR means Pharmacovigilance Rapid Alert System for Consumer Reporting. It was created by NAFDAC in September 2012 as a consumer pharmacovigilance feedback system.

Why is it important for me to send this information to NAFDAC?

Individual adverse drug reaction reports to NAFDAC can make a significant difference in ensuring the safety of a drug after it has been approved for use by NAFDAC and can lead to changes in how a drug is advertised or used in Nigeria including the possible removal from the Nigerian market. This is because consumer reporting is the most expedient method for NAFDAC to identify any new or threatening adverse drug reactions.

This article is intended to provide general information about the subject matter. Professional advice should be sought about specific circumstances.


Print Friendly, PDF & Email
About Ufuoma Akpotaire 319 Articles
Ufuoma is a Senior Editor and Director of Regulatory Policy at NLIPW. She assists clients in the protection of copyrights, trademarks and patents. She counsels clients regarding validity and infringement matters and has experience acting against the infringement of IP and addressing counterfeit issues. She holds a Masters degree (LL.M.) from Columbia Law School, New York and a law degree from the University of Nigeria (LL.B. Honors). She is admitted to practice law in Nigeria and in the State of New York. Ufuoma cut her teeth in the intellectual property practice groups of some of the largest law firms in Nigeria and has years of experience working with major non-profit organizations in New York. Email: